ArticleFrontiers in nutrition2026
Storage temperature as a determinant of probiotic long-term stability in commercial dietary supplements.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fueled by growing consumer demand for health-promoting interventions, probiotics have become widely used dietary supplements. Product quality assessment, however, still relies predominantly on label claims, highlighting the need to verify the presence and viability of declared microorganisms. Furthermore, the lack of harmonized methodologies and defined storage conditions complicates stability assurance and contributes to frequent discrepancies between declared and experimentally determined viable counts at the point of consumption. To address these gaps, we conducted a 12-month longitudinal evaluation of commercial multi-strain probiotic supplements stored under ambient, refrigeration, and freezing conditions, using culture-based enumeration of viable microbial counts. Results: Storage temperature was the primary determinant of viability. Under ambient storage conditions, a trend toward the greatest losses was observed, whereas lower storage temperatures appeared to better preserve bacterial counts over time. Taxon-specific patterns did not allow an unequivocal ranking of refrigeration versus freezing. Survival among bifidobacteria was strongly taxon-dependent, with Conclusion: Overall, our findings show that cold storage conditions, specifically refrigeration and freezing, most effectively preserve probiotic viability over time. These results underscore the importance of aligning formulation strategies, including strain selection, excipient composition, and encapsulation, with intended storage conditions to ensure sustained viability and consistent product quality throughout shelf life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.